Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASTERIAS: Triflusal vs Aspirin in Atherothrombosis
NCT02616497Phase 4Completed
- Sponsor
- University of Ioannina
- Start
- Sep 2015
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Triflusal in coronary artery disease (CAD), ischemic stroke, sponsored by University of Ioannina. Started Sep 2015; status: completed.
02
Drugs
Triflusal
03
Conditions
coronary artery disease (CAD)ischemic stroke
Beyond the preview
Go deeper on NCT02616497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02616497.